Authors:
Rudissaar, R
Pruus, K
Vaarmann, A
Pannell, P
Skrebuhhova-Malmros, T
Allikmets, L
Matto, V
Citation: R. Rudissaar et al., Acute trazodone and quipazine treatment attenuates apomorphine-induced aggressive behaviour in male rats without major impact on emotional behaviour or monoamine content post mortem, PHARMAC RES, 43(4), 2001, pp. 349-358
Citation: V. Matto et al., Apomorphine-induced aggressive behaviour in para-chlorophenylalanine-treated male rats: Implications to brain [H-3]Ketanserin binding and monoamine content, PHARM TOX, 88(3), 2001, pp. 147-151
Authors:
Skrebuhhova-Malmros, T
Allikmets, L
Matto, V
Citation: T. Skrebuhhova-malmros et al., Additive effect of clonidine and fluoxetine on apomorphine-induced aggressive behavior in adult male Wistar rats, ARCH MED R, 32(3), 2001, pp. 193-196
Authors:
Pruss, K
Skrebuhhova-Malmros, T
Rudissaar, R
Matto, V
Allikmets, L
Citation: K. Pruss et al., 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats, J PHYSL PH, 51(4), 2000, pp. 833-846
Authors:
Rudissaar, R
Pruus, K
Skrebuhhova-Malmros, T
Allikmets, L
Matto, V
Citation: R. Rudissaar et al., Involvement of GABAergic neurotransmission in the neurobiology of the apomorphine-induced aggressive behavior paradigm, a model of psychotic behaviorin rats, METH FIND E, 22(8), 2000, pp. 637-640
Authors:
Pruus, K
Rudissaar, R
Skrebuhhova-Malmros, T
Allikmets, L
Matto, V
Citation: K. Pruus et al., Development of apomorphine-induced aggressive behavior: Comparison of adult male and female Wistar rats, METH FIND E, 22(1), 2000, pp. 47-50
Authors:
Matto, V
Vaarmann, A
Rudissaar, R
Pruus, K
Skrebuhhova-Malmros, T
Allikmets, L
Citation: V. Matto et al., Apomorphine-induced aggressive behaviour and post-mortem monoamine contentin male Wistar rats, NEUROSCI L, 289(2), 2000, pp. 131-134
Authors:
Skrebuhhova-Malmros, T
Pruus, K
Rudissaar, R
Allikmets, L
Matto, V
Citation: T. Skrebuhhova-malmros et al., The serotonin 5-HT2A receptor subtype does not mediate apomorphine-inducedaggressive behaviour in male Wister rats, PHARM BIO B, 67(2), 2000, pp. 339-343
Authors:
Matto, V
Pourtier-Manzanedo, A
Vercamer, C
Soncin, F
Vandenbunder, B
Citation: V. Matto et al., Experimental angiogenesis: strategy for the functional study of the transcription factors of the Ets family during morphogenesis of the vascular tree, ANN ENDOCR, 61(1), 2000, pp. 61-69
Authors:
Harro, J
Haidkind, R
Harro, M
Modiri, AR
Gillberg, PG
Pahkla, R
Matto, V
Oreland, L
Citation: J. Harro et al., Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment, EUR NEUROPS, 10(1), 1999, pp. 5-16
Citation: V. Matto et al., Apomorphine-induced upregulation of serotonin 5-HT2A receptors in male rats is independent from development of aggressive behaviour, J PHYSL PH, 50(2), 1999, pp. 335-344
Citation: T. Skrebuhhova et al., [H-3]-ketanserin binding and elevated plus-maze behavior after chronic antidepressant treatment in DSP-4 and P-CPA pretreated rats: Evidence for partial involvement of 5-HT2A receptors, METH FIND E, 21(7), 1999, pp. 483-490
Citation: T. Skrebuhhova et al., 5-HT2A receptors mediate the effect of antidepressants in the elevated plus-maze test but have a partial role in the forced swimming test, MED SCI RES, 27(4), 1999, pp. 277-280
Authors:
Skrebuhhova-Malmros, T
Allikmets, L
Rudissaar, R
Pruus, K
Matto, V
Citation: T. Skrebuhhova-malmros et al., Ondansetron fails to reverse antidepressant-elicited antiexploratory effects in the elevated plus-maze and open field tests, MED SCI RES, 27(12), 1999, pp. 835-837
Authors:
Rudissaar, R
Pruus, K
Skrebuhhova, T
Allikmets, L
Matto, V
Citation: R. Rudissaar et al., Modulatory role of 5-HT3 receptors in mediation of apomorphine-induced aggressive behaviour in male rats, BEH BRA RES, 106(1-2), 1999, pp. 91-96
Citation: V. Matto et L. Allikmets, Acute and chronic citalopram treatment differently modulates rat exploratory behavior in the exploration box test: No evidence for increased anxiety or changes in the [H-3]raclopride binding, PHARMACOL, 58(2), 1999, pp. 59-69